[CLSTR]
< Back to situations

[ORGANIZATION]

Canadian Securities Exchange

Featured in 6 tracked stories · first seen

Situations

[QUIET] [BUSINESS] [CA]

Lobe Sciences sickle cell drug funding

2 clusters · 3 sources · last updated

Latest: Lobe Sciences raises $2.16 million for sickle cell drug development

Lobe Sciences Ltd. has completed a two-tranche non-brokered private placement of common shares, raising a total of $2,160,000. The company issued 25,411,762 shares at a price of $0.085 per share. The funds are intended

Also covered in